These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25295404)

  • 21. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
    Keast SL; Thompson D; Farmer K; Smith M; Nesser N; Harrison D
    J Manag Care Spec Pharm; 2014 Jun; 20(6):612-21. PubMed ID: 24856599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antipsychotic medications in treating schizophrenia among different financing and delivery systems.
    Bloom JR; Cheng JS; Hu TW; Kang SH; Wallace N
    J Ment Health Policy Econ; 2003 Dec; 6(4):163-71. PubMed ID: 14713723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia.
    Abouzaid S; Jutkowitz E; Foley KA; Pizzi LT; Kim E; Bates J
    Popul Health Manag; 2010 Oct; 13(5):247-54. PubMed ID: 20879905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.
    Mulcahy AW; Normand SL; Newcomer JW; Colaiaco B; Donohue JM; Lave JR; Keeler E; Sorbero MJ; Horvitz-Lennon M
    Psychiatr Serv; 2017 Dec; 68(12):1280-1287. PubMed ID: 28859580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.
    Soumerai SB; Zhang F; Ross-Degnan D; Ball DE; LeCates RF; Law MR; Hughes TE; Chapman D; Adams AS
    Health Aff (Millwood); 2008; 27(3):w185-95. PubMed ID: 18381404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics.
    Bera R; Offord S; Zubek D; Lau G; Lin J; Baker RA; Karson C
    J Med Econ; 2013; 16(4):522-8. PubMed ID: 23360177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.
    Bera R; Offord S; Zubek D; Lau G; Lin J; Karson C
    J Clin Psychopharmacol; 2014 Feb; 34(1):30-5. PubMed ID: 24135840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid's prior authorization program and access to atypical antipsychotic medications.
    Polinski JM; Wang PS; Fischer MA
    Health Aff (Millwood); 2007; 26(3):750-60. PubMed ID: 17485754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.
    Hartung DM; Middleton L; McFarland BH; Haxby DG; McDonagh MS; McConnell KJ
    Psychiatr Serv; 2013 Dec; 64(12):1236-42. PubMed ID: 23999754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicaid policies to contain psychiatric drug costs.
    Koyanagi C; Forquer S; Alfano E
    Health Aff (Millwood); 2005; 24(2):536-44. PubMed ID: 15757941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
    Van Dorn RA; Swanson JW; Swartz MS; Elbogen EB
    Ment Health Serv Res; 2005 Jun; 7(2):123-34. PubMed ID: 15974158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to potentially dangerous drug-drug interactions involving antipsychotics.
    Guo JJ; Wu J; Kelton CM; Jing Y; Fan H; Keck PE; Patel NC
    Psychiatr Serv; 2012 Nov; 63(11):1080-8. PubMed ID: 22910806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a discharge planning program on Medicaid coverage of state prisoners with serious mental illness.
    Wenzlow AT; Ireys HT; Mann B; Irvin C; Teich JL
    Psychiatr Serv; 2011 Jan; 62(1):73-8. PubMed ID: 21209303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expedited Medicaid Enrollment, Mental Health Service Use, and Criminal Recidivism Among Released Prisoners With Severe Mental Illness.
    Morrissey JP; Domino ME; Cuddeback GS
    Psychiatr Serv; 2016 Aug; 67(8):842-9. PubMed ID: 26975522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.